Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records

Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records

<p>Abstract</p> <p>Background</p> <p>Studies focusing on the add-on effects of angiotensin II type 1 receptor blockers (ARBs) other than their antihypertensive effect are receiving attention. However, the effects of prolonged administration of ARBs on lipid metabolism i...

Full description

Bibliographic Details
Main Authors:	Nishida Yayoi, Takahashi Yasuo, Nakayama Tomohiro, Soma Masayoshi, Kitamura Noboru, Asai Satoshi
Format:	Article
Language:	English
Published:	BMC 2010-08-01
Series:	Cardiovascular Diabetology
Online Access:	http://www.cardiab.com/content/9/1/38

Similar Items

Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
by: Yayoi Nishida, et al.
Published: (2020-04-01)

Candesartan in treating hypertension
by: L O Minushkina
Published: (2014-03-01)

Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension
by: N. M. Chikhladze, et al.
Published: (2008-12-01)

The comparison between combination of candesartan-amlodipine and candesartan-furosemide on blood pressure in hypertensive patients with chronic kidney disease
by: Dian Ayu Juwita, et al.
Published: (2022-07-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
by: T E Morozova
Published: (2013-06-01)

Effects of candesartan on cardiac and arterial structure and function in hypertensive subjects
by: James CS Spratt, et al.
Published: (2001-12-01)

CANDESARTAN IN CARDIOLOGY PRACTICE
by: N. A. Dzhaiani
Published: (2017-12-01)

Persistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats
by: Karin Skov, et al.
Published: (2001-03-01)

A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension
by: Zhenfeng Zheng, et al.
Published: (2011-09-01)

DYNAMICS OF PARAMETERS OF PROINFLAMMATORY ACTIVATION IN PATIENTS WITH HYPERTENSION UNDER INFLUENCE OF CANDESARTAN THERAPY
by: V. A. Vizir, et al.
Published: (2014-05-01)

Reversal of cardiovascular remodelling with candesartan
by: Lindsay Brown, et al.
Published: (2001-03-01)

Candesartan cilexetil in cardiovascular prevention
by: A. Ya. Ivleva
Published: (2007-12-01)

Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design
by: Niels H Andersen, et al.
Published: (2003-06-01)

A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension
by: Di Zhao, et al.
Published: (2019-01-01)

Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus
by: Yasufumi Seki, et al.
Published: (2023-10-01)

The safety and tolerability of candesartan cilexetil in CHF
by: Erland Erdmann, et al.
Published: (2000-03-01)

The Safety and Tolerability of Candesartan Cilexetil in CHF
by: Erland Erdmann, et al.
Published: (2000-03-01)

Functional candesartan loaded lipid nanoparticles for the control of diabetes-associated stroke: In vitro and in vivo studies
by: Dina M. Mahmoud, et al.
Published: (2024-06-01)

Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility
by: Thomas Mengden, et al.
Published: (2009-11-01)

Efficacy of azilsartan on left ventricular diastolic dysfunction compared with candesartan: J-TASTE randomized controlled trial
by: Shin Ito, et al.
Published: (2023-08-01)

Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension
by: Roberto Fogari, et al.
Published: (2007-09-01)

Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients
by: Nian Cao, et al.
Published: (2021-10-01)

Sibutramine monotherapy in arterial hypertension combined with obesity
by: S. V. Nedogoda, et al.
Published: (2009-08-01)

Effect of angiotensin II receptor blockers, candesartan, on osteoprotegerin level in hypertensive patients: Link between bone and RAAS
by: H Oz, et al.
Published: (2015-09-01)

Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects
by: Daniel Casellas, et al.
Published: (2001-03-01)

Benzodiazepine-related dementia risks and protopathic biases revealed by multiple-kernel learning with electronic medical records
by: Takashi Hayakawa, et al.
Published: (2023-06-01)

Antiproteinuric effect of candesartan cilexetil in patients with chronic glomerulonephritis
by: Kiyoshi Kurokawa, et al.
Published: (2002-09-01)

Pre-treatment with candesartan protects from cerebral ischaemia
by: Takeshi Ito, et al.
Published: (2001-09-01)

Beneficial Effect of Candesartan on Rat Diastolic Heart Failure
by: Ryotaro Wake, et al.
Published: (2005-01-01)

Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation
by: Jin Wook Lee, et al.
Published: (2023-05-01)

RENAISSANCE OF ARTERIAL HYPERTENSION MONOTHERAPY – THE POSITION OF THIAZIDE DIURETICS
by: T. V. Adasheva, et al.
Published: (2012-10-01)

Formulation and validation of Candesartan cilexetil-loaded nanosuspension to enhance solubility
by: Sarmad Al-Edresi, et al.
Published: (2024-03-01)

The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics
Published: (2005-03-01)

Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan
by: Antonio Núñez, et al.
Published: (2000-06-01)

Candesartan decreases the sympatho-adrenal and hormonal response to isolation stress
by: Ines Armando, et al.
Published: (2001-03-01)

Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria
by: Trefor Morgan, et al.
Published: (2004-06-01)

Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil
by: Vasilios Papademetriou, et al.
Published: (2001-03-01)

Cerebroprotective effects of angiotensin II receptor blockers: candesartan focus
by: O. D. Ostroumova, et al.
Published: (2018-09-01)

Enhancing the Oral Bioavailability of Candesartan Cilexetil Loaded Nanostructured Lipid Carriers: In Vitro Characterization and Absorption in Rats after Oral Administration
by: Walid Anwar, et al.
Published: (2020-10-01)

EFFECT OF CANDESARTAN ON PARAMETERS OFDAILYBLOOD PRESSURE IN PATIENTS WITH CHRONIC KIDNEYDISEASE ON HEMODIALYSIS
by: V. A. Vizir, et al.
Published: (2017-12-01)